Related Experiment Videos
Effect of beta-propiolactone inactivation of polyoma virus on viral functions
Abstract:
Polyoma virus was inactivated by treatment with beta-propiolactone. T-antigen production, polyoma-RNA synthesis, induction of host DNA synthesis (measured by incorporation of labeled thymidine into the cell culture), and in vitro transforming ability were inactivated to a similar degree by various beta-propiolactone concentrations (0.25% beta-propiolactone reduced these functions approximately 96%), whereas plaque-forming ability and the ability of the virus to replicate its DNA and to synthesize capsid antigen were inactivated by a given concentration of beta-propiolactone to a much greater degree (0.25% beta-propiolactone led to a reduction of plaque-forming ability of over 8 logs). The significance of these data and their relationship to previously published experiments are discussed.
Insights
Beta-propiolactone inactivates polyoma virus functions. Early functions like T-antigen production were similarly affected, while viral replication and plaque formation were significantly more impacted by beta-propiolactone treatment.
Area of Science:
- Virology
- Molecular Biology
- Biochemistry
Background:
- Polyoma virus is a DNA tumor virus with significant implications in oncogenesis.
- Understanding viral inactivation mechanisms is crucial for developing antiviral strategies and ensuring laboratory safety.
Purpose of the Study:
- To investigate the differential inactivation effects of beta-propiolactone on various polyoma virus functions.
- To compare the sensitivity of viral gene expression, DNA replication, and infectivity to beta-propiolactone treatment.
Main Methods:
- Polyoma virus was treated with varying concentrations of beta-propiolactone.
- Assays were performed to measure T-antigen production, polyoma-RNA synthesis, host DNA synthesis induction, in vitro transforming ability, plaque-forming ability, viral DNA replication, and capsid antigen synthesis.
Main Results:
- Beta-propiolactone inactivated T-antigen production, polyoma-RNA synthesis, host DNA synthesis induction, and in vitro transforming ability to a similar extent (approx. 96% reduction with 0.25% beta-propiolactone).
- Plaque-forming ability, viral DNA replication, and capsid antigen synthesis were inactivated to a much greater degree (over 8 log reduction in plaque-forming ability with 0.25% beta-propiolactone).
Conclusions:
- Beta-propiolactone exhibits differential inactivation kinetics against polyoma virus, with a more pronounced effect on viral replication and infectivity compared to early gene expression and transformation.
- These findings highlight the complex mechanisms of viral inactivation and provide insights into the distinct vulnerabilities of different viral processes.